BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Eli Lilly and Company Release: Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer

  June 4, 2007

   · 

  5 min read
• Pharm Country

  Xechem International Among Finalist As Prestigious Innovated Company for NJBIZ HealthCare Heroes Award

  June 4, 2007

   · 

  1 min read
• Drug Development

  Biothera’s Imprime PGG(TM) Enhanced Effectiveness of Avastin(R) in Cancer Study

  June 4, 2007

   · 

  1 min read
• Drug Development

  ZymoGenetics, Inc. Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia

  June 4, 2007

   · 

  4 min read
• Drug Development

  Bionovo, Inc.'s MF101 Shows Positive Safety, Tolerability and Efficacy in Phase 2 Trial

  June 4, 2007

   · 

  6 min read
• ReNeuron Announces New Data Concerning its ReNcell® Neural Stem Cell Lines

  June 4, 2007

   · 

  1 min read
• Drug Development

  Ariad Pharmaceuticals, Inc. Presents Positive Efficacy Data On AP23573, Novel mTOR Inhibitor, in Phase 2 Metastatic Endometrial Cancer Trial

  June 4, 2007

   · 

  1 min read
• Drug Development

  Ariad Pharmaceuticals, Inc. Presents Additional Efficacy Data on AP23573, Novel mTOR Inhibitor, in Phase 2 Advanced Sarcoma Trial

  June 4, 2007

   · 

  1 min read
• Business

  SQI Diagnostics Inc. Reports 2007 First Quarter Results

  June 4, 2007

   · 

  1 min read
• Drug Development

  AstraZeneca PLC Release: Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)

  June 4, 2007

   · 

  5 min read